| Application no. and date | 23722929.9 (espacenet) (Federated) (European Patent Register), 20230427 | | Patent/reg. no. and date | DK/EP 4288036, 20240807 | | Publication date | 20231213 | | Priority no. and date | US 202263335387 P, 20220427 | | EP pub. no. and date |
EP 4288036 20231213 | | Effective date | | | Applicant/owner | Kalvista Pharmaceuticals Limited, Porton Science Park
Bybrook Road
Porton Down
Wiltshire SP4 0BF, GB | | Applicant ref. no. | V478979DK00 | | Inventor | COOPER, John Alexander,
Salisbury, Wiltshire SP4 0BF, GB,
CROADSHAW, Oliver William,
Salisbury, Wiltshire SP4 0BF, GB,
IVERSON, Matthew Scott,
Cottonwood Heights, Utah 84093, US,
SCHIANO, Serena,
Salisbury, Wiltshire SP4 0BF, GB,
SMITH, Michael David,
Salt Lake City, Utah 84109, US,
ARROYO, Ana Catalina Ferreira,
Lawrenceville, NJ 08648, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 9/20 (2006.01) , A61P 43/00 (2006.01) | | Title | Formuleringer af en plasmakallikreinhæmmer | | Int. application no. | GB2023051120 | | Int. publication no. | WO2023209381 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
